| First Posted | New Trial Filing | Phase | Status |
|---|---|---|---|
| 2026-05-29 | NCT07614958 Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs… | Phase 3 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07508254 | Triple vs Dual Lipid-Lowering Therapy for LDL-C Reduction in Acute Coronary Syndrome | Acute Coronary Syndromes (ACS) | Not Yet Recruiting |
| Phase 3 | |||
| NCT07614958 | Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs… | Mixed Dyslipidemia | Recruiting |
| NCT07474649 | A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without… | Coronary Atherosclerosis | Not Yet Recruiting |
| Phase 2 | |||
| NCT07282821 | Bempedoic Acid Therapy for Polycystic Kidney Disease | ADPKD (Autosomal Dominant Polycystic Kidney Disease) | Not Yet Recruiting |
| Not specified | |||
| NCT07374861 | Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment… | Hypercholesterolemia | Recruiting |
| NCT06686615 | A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or… | Primary Hypercholesterolemiia | Recruiting |